169 related articles for article (PubMed ID: 34736068)
21. Design of Bifunctional Dendritic 5-Aminolevulinic Acid and Hydroxypyridinone Conjugates for Photodynamic Therapy.
Zhou T; Battah S; Mazzacuva F; Hider RC; Dobbin P; MacRobert AJ
Bioconjug Chem; 2018 Oct; 29(10):3411-3428. PubMed ID: 30249090
[TBL] [Abstract][Full Text] [Related]
22. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
[TBL] [Abstract][Full Text] [Related]
23. Protoporphyrin IX-gold nanoparticle conjugates as an efficient photosensitizer in cervical cancer therapy.
Eshghi H; Sazgarnia A; Rahimizadeh M; Attaran N; Bakavoli M; Soudmand S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):304-12. PubMed ID: 23993857
[TBL] [Abstract][Full Text] [Related]
24. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Sengar P; Juárez P; Verdugo-Meza A; Arellano DL; Jain A; Chauhan K; Hirata GA; Fournier PGJ
J Nanobiotechnology; 2018 Feb; 16(1):19. PubMed ID: 29482561
[TBL] [Abstract][Full Text] [Related]
25. The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro.
Wyld L; Reed MW; Brown NJ
Br J Cancer; 1998 May; 77(10):1621-7. PubMed ID: 9635837
[TBL] [Abstract][Full Text] [Related]
26. The influence of different illumination parameters on protoporphyrin IX induced cell death in squamous cell carcinoma cells.
Novak B; Heesen L; Schary N; Lübbert H
Photodiagnosis Photodyn Ther; 2018 Mar; 21():385-392. PubMed ID: 29427796
[TBL] [Abstract][Full Text] [Related]
27. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
28. Mitochondria-Targeting Polyamine-Protoporphyrin Conjugates for Photodynamic Therapy.
Taba F; Onoda A; Hasegawa U; Enoki T; Ooyama Y; Ohshita J; Hayashi T
ChemMedChem; 2018 Jan; 13(1):15-19. PubMed ID: 28961376
[TBL] [Abstract][Full Text] [Related]
29. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
30. Comparison of 5-aminolevulinic acid and its hexylester mediated photodynamic action on human hepatoma cells.
Ren QG; Wu SM; Peng Q; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):650-4. PubMed ID: 12198571
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of protoporphyrin-IX in rat Leydig cells following induction by 5-aminolevulinic acid and tramadol.
Wołuń-Cholewa M; Butowska W; Warchoł W
Photomed Laser Surg; 2007 Dec; 25(6):526-9. PubMed ID: 18158756
[TBL] [Abstract][Full Text] [Related]
32. Plasma membrane activatable polymeric nanotheranostics with self-enhanced light-triggered photosensitizer cellular influx for photodynamic cancer therapy.
Jia HR; Jiang YW; Zhu YX; Li YH; Wang HY; Han X; Yu ZW; Gu N; Liu P; Chen Z; Wu FG
J Control Release; 2017 Jun; 255():231-241. PubMed ID: 28442408
[TBL] [Abstract][Full Text] [Related]
33. Real-time, in vivo measurement of tissular pO2 through the delayed fluorescence of endogenous protoporphyrin IX during photodynamic therapy.
Piffaretti F; Novello AM; Kumar RS; Forte E; Paulou C; Nowak-Sliwinska P; van den Bergh H; Wagnières G
J Biomed Opt; 2012 Nov; 17(11):115007. PubMed ID: 23214178
[TBL] [Abstract][Full Text] [Related]
34. The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species.
Dogra Y; Ferguson DCJ; Dodd NJF; Smerdon GR; Curnow A; Winyard PG
Redox Biol; 2016 Oct; 9():90-99. PubMed ID: 27454766
[TBL] [Abstract][Full Text] [Related]
35. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
36. Addition of novel degenerate electrical waveform stimulation with photodynamic therapy significantly enhances its cytotoxic effect in keloid fibroblasts: first report of a potential combination therapy.
Sebastian A; Allan E; Allan D; Colthurst J; Bayat A
J Dermatol Sci; 2011 Dec; 64(3):174-84. PubMed ID: 22015050
[TBL] [Abstract][Full Text] [Related]
37. Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement.
Yang X; Palasuberniam P; Kraus D; Chen B
Int J Mol Sci; 2015 Oct; 16(10):25865-80. PubMed ID: 26516850
[TBL] [Abstract][Full Text] [Related]
38. Efficiency of 5-ALA mediated photodynamic therapy on hypoxic prostate cancer: a preclinical study on the Dunning R3327-AT2 rat tumor model.
Bozzini G; Colin P; Betrouni N; Maurage CA; Leroy X; Simonin S; Martin-Schmitt C; Villers A; Mordon S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):296-303. PubMed ID: 23993856
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the in vitro and in vivo effects of photodynamic therapy on prostate cancer by using new photosensitizers, protoporphyrin IX-polyamine derivatives.
Fidanzi-Dugas C; Liagre B; Chemin G; Perraud A; Carrion C; Couquet CY; Granet R; Sol V; Léger DY
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1676-1690. PubMed ID: 28188858
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence detection and depletion of T47D breast cancer cells from human mononuclear cell-enriched blood preparations by photodynamic treatment: Basic in vitro experiments towards the removal of circulating tumor cells.
Ziegler VG; Knaup J; Stahl D; Krammer B; Plaetzer K
Lasers Surg Med; 2011 Sep; 43(7):548-56. PubMed ID: 22057482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
